Debunks › Reality Denial › Cancer Is Just a Fungus

Testing "Cancer Is Just a Fungus"

"Cancer is just a fungus" is one of those claims that feels simple enough to be powerful. It says doctors have misunderstood cancer, tumors are actually fungal growths, Candida is the real enemy, and cheap antifungal or baking-soda treatments could cure what mainstream oncology keeps complicated. It sounds like a key that unlocks the whole problem. But when tested against pathology, genetics, microscopy, tumor behavior, fungal disease, and cancer treatment evidence, the key breaks in the lock. Cancer is not just a fungus. Cancer is a family of diseases in which human cells acquire changes that let them grow, survive, invade, and sometimes spread beyond normal control.

The careful version is more interesting than the myth. Fungi can infect people. Some fungal infections are serious, especially in immunocompromised patients. Microbes, including viruses, bacteria, and possibly fungi, can interact with cancer biology. Researchers are studying fungal communities in and around tumors, sometimes called the tumor mycobiome. But "fungi can be associated with some cancers" is not the same claim as "cancer is fungus." A footprint in a room is not the owner of the house. A microbe near a tumor is not automatically the tumor. A factor that may influence cancer is not the identity of cancer itself.

Contents

1. 1. What the claim says
2. 2. What cancer actually is
3. 3. What fungal infection actually is
4. 4. Pathology immediately separates cancer from fungus
5. 5. Genetics is the wall the claim cannot climb
6. 6. Metastasis behaves like human cancer, not spreading mold
7. 7. The Candida argument collapses
8. 8. Baking soda is not a cancer cure
9. 9. The real fungal nuance: tumor mycobiome research
10. 10. Why real treatments do not fit the fungus model
11. 11. Why this myth is dangerous
12. 12. Claim-by-claim field guide
13. 13. Final verdict
14. Sources

1. What the Claim Says

The "cancer is fungus" claim usually appears in one of three forms. The first says all cancer is Candida. The second says tumors are the body's defensive wall around fungal infection. The third says cancer may look like mutated human tissue, but the real cause is hidden fungal overgrowth, acidity, or yeast. The promised solution is usually sodium bicarbonate, antifungals, an alkaline diet, anti-sugar protocols, oxygen therapies, or some combination of "natural" products sold as suppressed cures.

The most famous modern promoter was Tullio Simoncini, who argued that cancer was caused by Candida and promoted sodium bicarbonate as treatment. The idea spread because it is emotionally satisfying. Cancer is terrifying because it is internal, diverse, mutating, and hard to treat. Fungus is familiar. Baking soda is cheap. A complicated disease becomes a simple invader. A long oncology appointment becomes a household remedy. A frightening diagnosis becomes a conspiracy story about a cure "they" do not want you to know.

The claim also borrows little pieces of truth. Candida can live in the human body. Fungal infections can happen. Cancer patients can get infections. Tumors can have acidic microenvironments. Some cancers are linked to infectious agents. Researchers study microbes in tumors. All of that is real. The trick is that the myth glues those facts together into a conclusion the facts do not support.

A serious version of the claim would need to pass basic tests:

• Do tumor cells look and test like fungal cells?
• Do tumors contain fungal genomes as the main replicating cancer lineage?
• Do cancers respond reliably to antifungals the way fungal infections do?
• Do metastases spread like fungal infection, or like related human cancer clones?
• Do known cancer mutations, inherited cancer syndromes, carcinogens, viral cancers, and targeted therapies make sense if cancer is fungus?
• Can baking soda kill cancer safely and reliably in humans, or is that a leap from pH theory?

The answer to those questions is devastating for the myth. Tumors are diagnosed as abnormal human tissues. Cancer cells carry human genomes with human mutations. Cancers are classified by tissue and cell type, not by fungal species. Metastases preserve the identity of the original cancer. Evidence-based treatments work through cancer biology, not through the assumption that every tumor is Candida. Fungi may sometimes be passengers, modifiers, opportunists, or research-relevant neighbors. They are not what cancer is.

Back to top

2. What Cancer Actually Is

The National Cancer Institute defines cancer as a disease in which some of the body's cells grow uncontrollably and spread to other parts of the body.¹ That is the center of the issue: the cells are the body's cells. They are not mushrooms, molds, yeasts, or alien organisms. They are human cells whose normal controls have broken down.

Normal human cells divide when the body needs new cells, stop when they should stop, die when badly damaged, and remain organized inside tissues. Cancer begins when that ordered process fails. Damaged or abnormal cells multiply when they should not. Some form tumors. Some invade nearby tissue. Some travel through blood or lymph and seed new tumors elsewhere. Blood cancers such as leukemias may not form a solid lump at all, which already creates a problem for the "tumor is fungal mass" story.

Cancer is not one disease. It is a large family of diseases. Lung adenocarcinoma, melanoma, acute myeloid leukemia, glioblastoma, pancreatic ductal adenocarcinoma, prostate cancer, cervical cancer, lymphoma, osteosarcoma, and breast cancer are not the same thing wearing different costumes. They arise from different tissues, carry different molecular drivers, behave differently, and respond to different treatments. A myth that reduces all of them to fungus is not simplifying accurately. It is erasing the evidence.

Cancer cells differ from normal cells in recognizable ways. NCI lists features such as growing without normal growth signals, ignoring stop-and-death signals, invading nearby areas, spreading to other parts of the body, recruiting blood vessels, hiding from the immune system, accumulating chromosomal changes, and using nutrients differently from normal cells.¹ Those are cancer-cell behaviors. They are not diagnostic features of Candida infection.

Cancer is also a genetic disease in the somatic sense. That does not mean every cancer is inherited. It means cancer is driven by changes in genes that control cell growth, survival, repair, and division. NCI explains that cancer-related genetic changes can come from random DNA mistakes as cells multiply, environmental carcinogens such as tobacco smoke and ultraviolet radiation, infections such as HPV, or inherited variants that increase risk.² That framework explains why cancer risk rises with age, why smoking causes lung cancer, why HPV vaccination prevents many cervical cancers, why BRCA variants raise breast and ovarian cancer risk, and why targeted drugs can work when a tumor has a specific driver mutation.

The fungus claim cannot explain that landscape. If all cancer is Candida, why do inherited mutations in DNA repair genes increase cancer risk? Why do ultraviolet mutations produce characteristic skin cancers? Why do HPV proteins disable tumor suppressor pathways? Why do EGFR inhibitors help selected lung cancers? Why does surgical removal of a localized tumor sometimes cure disease? Why does radiation damage cancer-cell DNA? Why do blood cancers exist without a fungal lump? The myth does not answer these questions. It floats above them.

A better summary is this: cancer is human biology gone wrong. It may be influenced by the environment, infection, immunity, inflammation, age, chance, inherited risk, and tissue context. But the malignant population itself is made of altered human cells.

Back to top

3. What Fungal Infection Actually Is

Fungi are their own category of organisms. Yeasts, molds, and mushrooms are fungi. MedlinePlus explains that fungi live in air, soil, plants, water, and the human body, and that only about half of all types are harmful. Fungal infections, or mycoses, are caused by fungi, often beginning in the lungs or skin when spores are inhaled or land on the body. People are more likely to get fungal infections when their immune systems are weakened or after antibiotic use.³

That is very different from cancer. A fungal infection is an infection by an organism. It may be visible on microscopy, grow in culture, be identified by fungal DNA tests, show fungal structures, respond to antifungal drugs, and sometimes spread in a pattern consistent with infection. Ringworm, candidiasis, histoplasmosis, aspergillosis, cryptococcosis, and valley fever are not cancers. They have their own diagnostic methods and treatments.

Some fungal infections are superficial and annoying. Others are life-threatening. CDC notes that fungal diseases and antifungal resistance are increasing worldwide, that misdiagnosis is common, and that organisms such as Aspergillus and Candida auris can cause serious illness in vulnerable people.⁴ So the debunk is not "fungus is fake" or "fungal disease does not matter." Fungal disease absolutely matters. It just is not identical to cancer.

Cancer patients can be at higher risk of fungal infections because cancer or cancer treatment can weaken immune defenses. Chemotherapy, stem cell transplant, corticosteroids, targeted immune-altering drugs, low white blood cell counts, catheters, hospitalization, antibiotics, and damaged mucosal barriers can create opportunities for fungi. That means a cancer patient with fever, lung lesions, mouth thrush, bloodstream infection, or skin findings may need serious evaluation for fungal disease.

But notice the direction: cancer and its treatment can make fungal infection more likely. That does not mean the cancer itself is a fungus. A person with severe burns may develop infection; the burn is not bacteria. A person with HIV may develop fungal disease; HIV is not fungus. A person with leukemia may develop candidemia; leukemia is not Candida. Comorbidity is not identity.

The myth survives by blurring these categories. It shows that fungi exist in sick people, then calls the sickness fungus. It shows that Candida can overgrow, then says every tumor is Candida. It shows that antifungal medicine can treat fungal infection, then implies it should treat cancer. Each step sounds smooth in a video. Each step fails in a clinic, pathology lab, and genetics lab.

Back to top

4. Pathology Immediately Separates Cancer From Fungus

The fastest way to break the myth is to ask what pathologists see. Cancer diagnosis often depends on tissue: a biopsy is taken, processed, stained, and examined under a microscope. Pathologists do not diagnose cancer by guessing. They look at architecture, cell shape, nuclear features, invasion, mitotic activity, necrosis, margins, lymphovascular invasion, and markers that reveal tissue origin. When needed, they use immunohistochemistry, molecular testing, flow cytometry, cytogenetics, and sequencing.

Fungi do not look like malignant human cells. Yeast forms, hyphae, pseudohyphae, spores, and fungal cell walls have recognizable structures. Special stains can highlight fungi. Cultures and molecular tests can identify fungal organisms. A squamous cell carcinoma is not going to become Candida under a microscope because someone changed the story on social media. A lymphoma does not have the cell markers of a yeast infection. A glioblastoma does not have fungal architecture. These are not subtle categories.

Cancer Research UK addresses the myth directly: cancer cells are clearly not fungal in origin, cancer is not always white, and there is no evidence that Candida causes all cancer. They also point out that there is plenty of evidence going back over a century that cancer starts from faults in our own cells.⁵ That is the obvious point the myth tries to run past. Pathologists can see the difference between a human tumor and fungal infection.

Tumors also preserve tissue identity. A colon adenocarcinoma expresses markers and morphology consistent with gland-forming intestinal epithelial origin. A melanoma shows melanocytic lineage. A lymphoma expresses immune-cell markers. A prostate cancer metastasis in bone is still prostate cancer, not bone fungus. A breast cancer metastasis in liver is still breast cancer, not liver Candida. This is routine medicine, and it makes no sense if all tumors are fungal colonies.

The myth sometimes says cancer is "white" and therefore fungal. This is not an argument. Some tumors are pale. Some are dark, red, yellow, necrotic, hemorrhagic, mucinous, pigmented, cystic, friable, or mixed. Melanoma can be black or brown because of melanin. Some tumors bleed. Some tumors calcify. Some tumors contain fat. Gross color is not a species diagnosis. If color proved identity, pathology would be a paint chart. It is not.

Another version says tumors are the body's protective capsule around fungus. But tumors invade, destroy, seed metastases, recruit blood vessels, evolve resistance, and sometimes kill by replacing normal organ function. They do not behave like neatly encapsulated fungal quarantines. Some benign lesions are encapsulated. Some infections form granulomas or abscesses. Some tumors provoke immune reactions. But "the body walls things off sometimes" does not make malignant tissue a fungal bunker.

If the fungus model were true, oncology pathology departments around the world would be making the same embarrassing mistake every day, across thousands of hospitals, cancer types, molecular tests, autopsies, animal models, and clinical trials. The claim requires not one error but a global inversion of basic histology. That is not impossible in the abstract, but it would require huge evidence. It has none.

Back to top

5. Genetics Is the Wall the Claim Cannot Climb

Modern cancer genetics is the hardest problem for "cancer is fungus." Tumors carry human DNA with cancer-driving alterations. Those alterations can be sequenced, compared with the patient's normal tissue, tracked through treatment, and used to select therapies. NCI explains that cancer is caused by changes to genes that control how cells function, especially how they grow and divide, and that scientists have found hundreds of DNA and genetic changes that help cancer form, grow, and spread.²

This is not an abstract claim. A lung cancer may have an EGFR mutation, ALK fusion, KRAS mutation, ROS1 rearrangement, BRAF mutation, MET exon skipping, RET fusion, or NTRK fusion. A melanoma may carry BRAF V600E. Chronic myeloid leukemia is defined by BCR-ABL1. Certain breast cancers amplify HER2. Some colorectal cancers have mismatch-repair deficiency. These are changes in human cancer cells. They are not fungal species names.

Biomarker testing makes this practical. NCI describes biomarker testing as looking for genes, proteins, and other substances that provide information about cancer and help doctors choose treatment. Some cancer treatments only work when cancers have certain biomarkers, and cancer cells can have different patterns even among people with the same cancer type.⁶ That is precision oncology. It only makes sense because cancer cells are altered human cells with actionable features.

If cancer were simply Candida, tumor sequencing should reveal Candida as the primary malignant lineage. Antifungal susceptibility testing should replace tumor molecular profiling. A breast tumor and a leukemia should be variants of the same fungal infection. Cancer classification would collapse into mycology. But that is not what happens. Tumors are genetically related to the patient, not to an invading fungus.

Inherited cancer syndromes are another problem. BRCA1 and BRCA2 variants raise risk because DNA repair pathways matter. Lynch syndrome raises risk because mismatch repair matters. Familial adenomatous polyposis raises colorectal cancer risk because APC pathway disruption matters. Retinoblastoma risk involves RB1. These inherited risks do not prove that a person inherited fungus. They show that inherited changes in human genes can predispose human cells to become malignant.

Carcinogens are also hard for the fungus myth. Tobacco smoke, ultraviolet radiation, asbestos, aflatoxin, ionizing radiation, and some infections increase cancer risk through known or studied biological pathways involving DNA damage, inflammation, cell turnover, immune evasion, or viral oncogene activity. The exact details vary, but the common theme is altered cell regulation. "Candida did it" does not explain why smoking creates a characteristic lung-cancer risk, why UV exposure creates skin mutations, or why HPV vaccination prevents many cervical cancers.

Cancer evolution within a patient also points away from fungus. Tumors accumulate additional changes. Resistant subclones emerge after treatment. A metastasis may share trunk mutations with the primary tumor but acquire branch mutations. Liquid biopsies can detect tumor DNA in blood. This is clonal evolution of human malignant cells. A fungal infection model does not predict this pattern.

The myth can survive only by ignoring the entire molecular era of oncology. That is not a minor oversight. It is like claiming lightning is caused by dragons while refusing to discuss charge separation, electric fields, voltage, thunderstorm structure, and measurements. A story that avoids the main evidence is not a better explanation.

Back to top

6. Metastasis Behaves Like Human Cancer, Not Spreading Mold

Metastasis is the process by which cancer spreads from one part of the body to another. NCI describes cancerous tumors as able to invade nearby tissues and travel to distant places in the body to form new tumors.¹ Metastasis is a major reason cancer can be deadly, because cells from the original cancer can colonize organs that they should never occupy.

The key point is that a metastasis remains biologically related to the original cancer. Breast cancer that spreads to bone is still breast cancer. Colon cancer that spreads to liver is still colon cancer. Melanoma that spreads to brain is still melanoma. Pathologists and oncologists do not treat a liver metastasis from colon cancer as primary liver cancer, and they certainly do not treat it as a new fungal colony. They trace its identity by morphology, markers, clinical context, and molecular features.

This makes sense if cancer is a human-cell lineage that has acquired invasive and migratory capacity. It does not make sense if all tumors are fungus. A fungal infection spreading through the body would be diagnosed as disseminated fungal infection. It would have fungal organisms, fungal tests, and antifungal treatment logic. Metastatic carcinoma is not that.

The patterns of metastasis also differ by cancer type. Prostate cancer often spreads to bone. Colon cancer often spreads to liver. Certain melanomas and lung cancers can spread to brain. Ovarian cancer often spreads within the peritoneal cavity. These patterns reflect anatomy, blood flow, lymphatic drainage, tumor-cell adhesion, tissue microenvironments, immune interactions, and cancer-cell biology. They are not explained by the blanket claim that Candida is everywhere.

Blood cancers create another challenge. Leukemia is cancer of blood-forming tissues. It can involve blood, bone marrow, spleen, lymph nodes, and other sites. It may not form a solid tumor. It is diagnosed with blood counts, marrow examination, flow cytometry, cytogenetics, and molecular testing. If cancer is really fungal mass, what is leukemia? If the answer becomes "fungus in the blood," then ordinary leukemia diagnostics should reveal that. They do not.

A good theory explains the hard cases. The fungus theory explains the easy emotional image of a white lump and breaks everywhere else. Cancer biology explains solid tumors, blood cancers, invasion, metastasis, recurrence, resistance, inherited risk, carcinogens, and targeted therapy. That is why medicine uses cancer biology instead of Candida mythology.

Back to top

7. The Candida Argument Collapses

Candida is a real genus of yeasts, and Candida infections are real. Candida can live normally on and in the body. It can cause thrush, vaginal yeast infections, skin infections, bloodstream infections, and invasive disease, especially in vulnerable patients. None of that means all cancer is Candida.

Cancer Research UK notes that Candida is part of the normal array of microbes that live in and on people, and that the immune system usually keeps it in check. Infections can become more serious in people with compromised immune systems.⁵ That description fits ordinary medical understanding: Candida can be commensal, opportunistic, or pathogenic depending on context. It does not secretly become every cancer.

If Candida caused all cancer, several things should be obvious. People with Candida colonization should predictably develop cancer. Cancer should be prevented by eliminating Candida. Antifungal treatment should reliably shrink tumors. Tumor biopsies should show Candida as the central disease process. Cancer types should cluster by fungal exposure, not by tissue, genes, age, carcinogens, inherited risk, and known oncogenic infections. The world does not look like that.

The claim also confuses "associated with" and "caused by." Candida or other fungi may be found in some cancer contexts. That can happen for many reasons. Tumors may create altered local environments. Treatments may weaken barriers. Immune changes may permit colonization. Inflammation may change microbial communities. Some microbes may influence tumor behavior. Some findings may even be contamination or technical artifact if not carefully controlled. None of those options equals "the tumor is fungus."

The existence of infection-associated cancers also does not save the claim. HPV can cause cervical and other cancers. Hepatitis B and C can contribute to liver cancer. Epstein-Barr virus is linked to some lymphomas and nasopharyngeal carcinoma. Helicobacter pylori can contribute to stomach cancer. These examples prove that infections can influence cancer risk. They do not prove that cancer is the infectious organism. HPV-associated cervical cancer is still malignant human epithelial cells. H. pylori-associated gastric cancer is not a bacterium pretending to be a stomach tumor. The pathogen can be a cause, cofactor, or risk factor without being the cancer itself.

That distinction is basic. A match can start a house fire, but the fire is not a match. A virus can help transform a cell, but the resulting malignancy is not simply the virus. A fungus may affect inflammation or immunity in some settings, but a cancer cell remains a cancer cell. The myth depends on refusing that distinction.

Back to top

8. Baking Soda Is Not a Cancer Cure

The fungus claim is usually paired with sodium bicarbonate, or baking soda. The pitch says that because cancer is fungus, and fungus supposedly cannot survive in alkaline conditions, baking soda can cure cancer by alkalizing the tumor or body. Sometimes this is sold as drinking baking soda. Sometimes it is injected. Sometimes it is wrapped in language about pH, oxygen, sugar, and "terrain."

There are several problems. First, sodium bicarbonate is not the standard treatment for proven fungal infections. Cancer Research UK states this directly: injecting tumors with baking soda is not even the treatment used for proven fungal infections, let alone cancer.⁵ Real fungal infections are diagnosed and treated with antifungal medications chosen according to organism, site, severity, immune status, and drug susceptibility.

Second, the body tightly regulates blood pH. You cannot safely "alkalize your body" into a cancer-free state. Blood that becomes too alkaline creates metabolic alkalosis, which can be dangerous. Local tumor acidity is a real research topic, but local tumor microenvironment is not the same as whole-body pH folklore. A tumor may have acidic regions because of metabolism, oxygen gradients, perfusion, and waste handling. That does not mean drinking or injecting baking soda cures cancer.

Third, laboratory and animal pH research does not equal a human cure. Some research explores whether altering tumor acidity might affect metastasis, drug delivery, or treatment response. That is legitimate science. But "scientists study tumor pH" does not mean "baking soda cures cancer." Many ideas look interesting in cells or animals and fail in humans because dose, delivery, toxicity, tumor heterogeneity, metabolism, and physiology are brutally complicated.

Fourth, replacing oncology with baking soda can waste the window in which cancer is most treatable. Cancer stage matters. A localized cancer may be curable with surgery, radiation, systemic therapy, or combinations. A delayed cancer may become metastatic, resistant, or unresectable. The harm is not only direct toxicity. The harm is time.

Fifth, the claim contradicts itself. If cancer is fungus, antifungal therapy should be the central treatment. If cancer is acidity, alkalinity should be the central treatment. If cancer is sugar, diet should be the central treatment. If cancer is immune failure, immune restoration should be the central treatment. Alternative cancer narratives often mix all of these because the goal is not coherent biology. The goal is to keep the patient inside the alternative system.

Baking soda has legitimate medical uses under medical supervision. It can be used in specific acid-base disorders and other clinical contexts. That does not make it a universal anticancer drug. Water is medically useful too; that does not make drowning a treatment.

Back to top

9. The Real Fungal Nuance: Tumor Mycobiome Research

The strongest-looking modern rescue for the myth is tumor mycobiome research. Researchers have detected fungal DNA or fungal cells associated with certain cancers. Some studies suggest fungal communities may correlate with cancer type, inflammation, immune activity, metastasis, treatment response, or survival. This is real enough to discuss seriously.

The American Association for Cancer Research summarized recent findings by noting correlations between fungi and cancer traits or outcomes. Candida-group fungi, for example, have been associated in some studies with inflammation and immune activation in stomach cancer, gene-expression changes in head-and-neck and colon cancers, metastasis in colon cancers, and reduced survival in some gastrointestinal cancers.⁷

But the same AACR discussion gives the crucial caution: researchers could not determine whether the observed associations were causal. Fungi might influence tumor progression, or fungal growth might be a consequence of environmental changes created by cancer.⁷ That is the whole difference between science and myth. Science says, "We found an association. We need to understand direction, mechanism, contamination controls, and clinical relevance." The myth says, "Fungi were found. Cancer is fungus. Buy baking soda."

Tumor-microbiome research is not an embarrassment to oncology. It is part of oncology. Cancer researchers already study bacteria, viruses, fungi, immunity, metabolism, stromal cells, inflammation, angiogenesis, and treatment response. The field is complex because tumors are ecosystems. A tumor includes malignant cells, immune cells, blood vessels, fibroblasts, extracellular matrix, dead tissue, metabolites, nerves, microbes, and signals. Saying microbes may matter is not saying malignant cells do not exist.

It is also possible that fungal signatures may one day help with diagnosis or prognosis. Fungal DNA in blood or tissue might become a biomarker in selected settings. Some antifungal or microbiome-modulating interventions might eventually prove useful as adjuncts for certain cancers. That would still not validate the claim that cancer is just fungus. It would mean cancer care became more precise by adding one more layer of biology.

The correct position is therefore neither denial nor hype. Do not deny that fungi can be relevant to cancer biology. Do not inflate relevance into identity. "Tumors can have a mycobiome" is a research statement. "Tumors are Candida" is a false medical claim.

Back to top

10. Why Real Treatments Do Not Fit the Fungus Model

Cancer treatment is not random. NCI lists major treatment categories such as surgery, chemotherapy, hormone therapy, hyperthermia, immunotherapy, photodynamic therapy, radiation therapy, stem cell transplant, targeted therapy, and more.⁸ These treatments are not all interchangeable, and they are not chosen because doctors forgot about fungus. They are chosen based on cancer type, stage, biology, patient health, goals of care, biomarkers, and evidence from clinical trials.

Surgery fits the cancer model because localized malignant tissue can sometimes be removed before it spreads. If a tumor is a fungal infection, cutting it out would not be expected to cure systemic fungal disease in the same way. Yet many early cancers are cured by local treatment.

Radiation therapy fits the cancer model because high-dose radiation damages DNA and can kill cells that cannot repair the damage. It is used in carefully planned fields to treat tumors while limiting harm to normal tissue. If cancer were Candida, radiation oncology would make much less sense as a mainstay of treatment across many cancers.

Chemotherapy fits the cancer model because many drugs exploit features of rapidly dividing or vulnerable cancer cells. Chemotherapy can also harm normal fast-dividing cells, which is why side effects occur. The fact that chemotherapy has side effects does not mean cancer is fungus. It means targeting uncontrolled cell division is hard because the body also has normal dividing cells.

Hormone therapy fits the cancer model because some breast and prostate cancers depend on hormone signaling. Blocking estrogen or androgen pathways can slow or stop growth in selected cancers. That makes sense if tumor cells carry hormone-sensitive human pathways. It does not make sense as a Candida treatment.

Targeted therapy fits the cancer model because drugs can interfere with specific proteins or pathways that cancer cells rely on. NCI describes targeted therapy as treatment that targets proteins controlling how cancer cells grow, divide, and spread, and notes that it is foundational to precision medicine.⁹ That framework is impossible to reconcile with a one-size-fits-all fungus theory. EGFR-mutant lung cancer, HER2-positive breast cancer, BCR-ABL leukemia, and BRAF-mutant melanoma are not four disguises worn by Candida.

Immunotherapy fits the cancer model because immune systems can recognize and attack abnormal human cells, while cancer cells can evade or suppress immune attack. Checkpoint inhibitors, CAR T cells, monoclonal antibodies, and other immune approaches manipulate the relationship between immune cells and cancer cells. Again, this is not mycology. It is cancer immunology.

Stem cell transplant fits the model for certain blood cancers because the disease involves blood-forming tissues and immune systems. Biomarker testing fits the model because cancers carry different molecular features. Clinical trials fit the model because treatments must be tested against specific disease contexts. The whole structure of oncology would be bizarre if all cancers were one fungus.

Back to top

11. Why This Myth Is Dangerous

Some misinformation is merely silly. Cancer misinformation is not. It can kill by replacing effective care, delaying diagnosis, bankrupting desperate families, and training patients to distrust the people trying to help them. The "cancer is fungus" myth is especially dangerous because it does not simply say "try this alongside your care." It often says the whole cancer model is wrong and oncology is a scam. That is a direct attack on treatment adherence.

The myth also preys on reasonable fear. Cancer treatments can be brutal. Surgery can be frightening. Radiation can cause fatigue, burns, swallowing problems, or long-term complications. Chemotherapy can cause nausea, hair loss, immune suppression, neuropathy, infertility, and other harms. Immunotherapy can trigger autoimmune-like effects. Targeted therapies can cause serious side effects. Patients are not stupid for wanting something gentler.

But gentler is not the same as effective. A pleasant falsehood can be more dangerous than a harsh treatment. Evidence-based cancer care is not perfect, and no honest oncologist says it is. But it is built from biology, trials, survival data, adverse-event monitoring, pathology, imaging, staging, and constant revision. Baking-soda cancer cures are built from anecdotes, simplifications, and conspiracy logic.

The myth also damages the public understanding of real fungal disease. Fungal infections are already underrecognized and sometimes difficult to diagnose. CDC notes that fungal diseases are increasing worldwide and that misdiagnosis is common.⁴ Turning fungus into a universal cancer explanation does not help fungal-disease awareness. It makes people worse at distinguishing real infections from unrelated problems.

There is also a spiritual and emotional danger. Alternative cancer cures often imply that patients who worsen did not alkalize enough, detox enough, believe enough, avoid sugar enough, or resist doctors enough. That adds blame to suffering. Cancer patients do not need a morality play built on bad biology. They need truthful information, competent care, second opinions when appropriate, symptom support, and people who will not exploit their fear.

The best safety rule is simple: any cancer claim that tells a patient to abandon oncology, skip biopsy, reject staging, avoid surgery, refuse radiation, stop systemic therapy, or trust a universal cure should be treated as dangerous until proven otherwise. Real medicine can be questioned, and second opinions can be wise. But the replacement still has to prove itself with diagnosis-specific evidence, survival data, toxicity monitoring, and transparent clinical results. "It worked for a person online" is not enough when the cost of being wrong may be progression from treatable disease to incurable disease.

A good response to this myth should be direct but not cruel. People who believe it may be scared, grieving, betrayed by prior medical experiences, overwhelmed by jargon, or trying to save someone they love. The answer is not mockery. The answer is clarity: cancer is not a fungus, baking soda is not a cure, and abandoning evidence-based care is dangerous.

Back to top

12. Claim-by-Claim Field Guide

The field guide reveals the central problem: every version of the claim depends on a category error. It confuses cause with identity, association with proof, infection with malignancy, and research hypothesis with clinical cure.

Back to top

13. Final Verdict

Sources

1. National Cancer Institute, "What Is Cancer?". NCI defines cancer, describes uncontrolled growth, invasion, metastasis, cancer-cell differences, and cancer as a genetic disease.
2. National Cancer Institute, "The Genetics of Cancer". NCI explains how cancer-related genetic changes arise from cell-division errors, carcinogens, infections, and inherited variants.
3. MedlinePlus, "Fungal Infections". MedlinePlus summarizes fungal organisms, routes of infection, risk factors, and antifungal treatment categories.
4. Centers for Disease Control and Prevention, "Fungal Diseases". CDC summarizes fungal disease concerns, misdiagnosis, antifungal resistance, and examples such as Aspergillus, Candida auris, candidiasis, histoplasmosis, and valley fever.
5. Cancer Research UK, "Don't believe the hype: 10 persistent cancer myths debunked". Cancer Research UK directly addresses the claim that cancer is a fungus and sodium bicarbonate is the cure.
6. National Cancer Institute, "Biomarker Testing for Cancer Treatment". NCI explains how tumor markers and genetic changes can guide treatment choices.
7. American Association for Cancer Research, "The Fungus Within Us: The Mycobiome's Emerging Role in Cancer". AACR summarizes emerging research on fungal communities associated with tumors and cautions that causality is not yet established.
8. National Cancer Institute, "Types of Cancer Treatment". NCI lists major cancer treatment categories and notes that treatment depends on cancer type and stage.
9. National Cancer Institute, "Targeted Therapy to Treat Cancer". NCI explains targeted therapy as treatment aimed at proteins and changes that help cancer cells grow, divide, and spread.

Back to top